Synaptogenix Inc (SNPX)

[runncoach]

Don't risk more than one can afford to lose. AD trials fail....over and over they fail. Normally a group can benefit but not enough to pull the entire group to stat significance. Yet again the trial produced positive gains but in large part to placebo effect it would seem. Remains to be seen where it goes from here but probably not favorably for shareholders imo.